3063 related articles for article (PubMed ID: 8669492)
1. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
2. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E alleles and brain vascular pathology in Alzheimer's disease.
Kalaria RN; Cohen DL; Premkumar DR
Ann N Y Acad Sci; 1996 Jan; 777():266-70. PubMed ID: 8624096
[TBL] [Abstract][Full Text] [Related]
4. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
5. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy.
Greenberg SM; Rebeck GW; Vonsattel JP; Gomez-Isla T; Hyman BT
Ann Neurol; 1995 Aug; 38(2):254-9. PubMed ID: 7654074
[TBL] [Abstract][Full Text] [Related]
7. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy.
Nicoll JA; Burnett C; Love S; Graham DI; Dewar D; Ironside JW; Stewart J; Vinters HV
Ann Neurol; 1997 Jun; 41(6):716-21. PubMed ID: 9189032
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of severe cerebral amyloid angiopathy and influence of APOE genotype in persons with pathologically verified Alzheimer disease.
Ringman JM; Sachs MC; Zhou Y; Monsell SE; Saver JL; Vinters HV
JAMA Neurol; 2014 Jul; 71(7):878-83. PubMed ID: 24797962
[TBL] [Abstract][Full Text] [Related]
9. APOE and cerebral amyloid angiopathy in community-dwelling older persons.
Yu L; Boyle PA; Nag S; Leurgans S; Buchman AS; Wilson RS; Arvanitakis Z; Farfel JM; De Jager PL; Bennett DA; Schneider JA
Neurobiol Aging; 2015 Nov; 36(11):2946-2953. PubMed ID: 26341746
[TBL] [Abstract][Full Text] [Related]
10. Two types of sporadic cerebral amyloid angiopathy.
Thal DR; Ghebremedhin E; Rüb U; Yamaguchi H; Del Tredici K; Braak H
J Neuropathol Exp Neurol; 2002 Mar; 61(3):282-93. PubMed ID: 11895043
[TBL] [Abstract][Full Text] [Related]
11. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage.
Nicoll JA; McCarron MO
Amyloid; 2001 Jul; 8 Suppl 1():51-5. PubMed ID: 11676291
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy in a 95+ cohort: complement activation and apolipoprotein E (ApoE) genotype.
Tanskanen M; Lindsberg PJ; Tienari PJ; Polvikoski T; Sulkava R; Verkkoniemi A; Rastas S; Paetau A; Kiuru-Enari S
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):589-99. PubMed ID: 16281907
[TBL] [Abstract][Full Text] [Related]
13. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
14. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
15. Senile dementia associated with amyloid beta protein angiopathy and tau perivascular pathology but not neuritic plaques in patients homozygous for the APOE-epsilon4 allele.
Vidal R; Calero M; Piccardo P; Farlow MR; Unverzagt FW; Méndez E; Jiménez-Huete A; Beavis R; Gallo G; Gomez-Tortosa E; Ghiso J; Hyman BT; Frangione B; Ghetti B
Acta Neuropathol; 2000 Jul; 100(1):1-12. PubMed ID: 10912914
[TBL] [Abstract][Full Text] [Related]
16. APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis.
Rannikmäe K; Kalaria RN; Greenberg SM; Chui HC; Schmitt FA; Samarasekera N; Al-Shahi Salman R; Sudlow CL
J Neurol Neurosurg Psychiatry; 2014 Mar; 85(3):300-5. PubMed ID: 24163429
[TBL] [Abstract][Full Text] [Related]
17. ApoA1, ApoJ and ApoE Plasma Levels and Genotype Frequencies in Cerebral Amyloid Angiopathy.
Montañola A; de Retana SF; López-Rueda A; Merino-Zamorano C; Penalba A; Fernández-Álvarez P; Rodríguez-Luna D; Malagelada A; Pujadas F; Montaner J; Hernández-Guillamon M
Neuromolecular Med; 2016 Mar; 18(1):99-108. PubMed ID: 26661731
[TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
McCarron MO; Nicoll JA; Stewart J; Ironside JW; Mann DM; Love S; Graham DI; Dewar D
J Neuropathol Exp Neurol; 1999 Jul; 58(7):711-8. PubMed ID: 10411341
[TBL] [Abstract][Full Text] [Related]
19. Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer's disease pathology: a population-based autopsy study in an admixed sample.
Paradela RS; Justo AFO; Paes VR; Leite REP; Pasqualucci CA; Grinberg LT; Naslavsky MS; Zatz M; Nitrini R; Jacob-Filho W; Suemoto CK
Acta Neuropathol Commun; 2023 Dec; 11(1):205. PubMed ID: 38115150
[TBL] [Abstract][Full Text] [Related]
20. Capillary cerebral amyloid angiopathy identifies a distinct APOE epsilon4-associated subtype of sporadic Alzheimer's disease.
Thal DR; Papassotiropoulos A; Saido TC; Griffin WS; Mrak RE; Kölsch H; Del Tredici K; Attems J; Ghebremedhin E
Acta Neuropathol; 2010 Aug; 120(2):169-83. PubMed ID: 20535486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
